TECH
US EQUITY
Health Care
Life Sciences Tools & Services
CIK: 842023
Bio-Techne (TECH) Quant Factor Diagnostic & Fair Value Model
Bio-Techne (Ticker: TECH) is listed in the Health Care sector (Life Sciences Tools & Services). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$72.55
-0.10%
Latest Close (2026-10-23)
Market Cap: $11.39B
P/E Ratio: 15.6
Momentum Strength
3M / 12M
+1.30%
1M: -0.03%
12M: +13.73%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
48.4
SMA50: $72.42
SMA200: $63.00
Valuation Multiplier
Trailing
15.6
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
TECH trades within a typical sector multiple band (15.6x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 842023 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-K | 2026-06-30 | 2026-08-24 | $1.22B | - | $292.07M | $1.16 |
| 10-K | 2025-06-30 | 2026-08-24 | $1.22B | $73.40M | $287.56M | $0.46 |
| 10-K | 2024-06-30 | 2026-08-24 | $1.16B | $168.10M | $298.98M | $1.05 |
| 10-Q | 2026-03-31 | 2026-05-06 | $311.42M | $51.05M | $196.66M | $0.32 |
| 10-Q | 2025-06-30 | 2026-05-06 | - | - | - | - |
| 10-Q | 2025-03-31 | 2026-05-06 | $316.18M | $22.59M | $189.35M | $0.14 |
| 10-Q | 2025-12-31 | 2026-02-04 | $295.88M | $38.01M | $110.00M | $0.24 |
| 10-Q | 2024-12-31 | 2026-02-04 | $297.03M | $34.89M | $148.24M | $0.22 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Bio-Techne (TECH) valuation multiples, momentum factors, and point-in-time filing conventions.
How should TECH's current valuation multiple be interpreted? ↓
TECH trades at a trailing P/E of 15.6x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are TECH's key momentum and technical factor indicators? ↓
As of the latest close, TECH shows a 1-month return of -0.03%, 3-month return of +1.30%, and 12-month return of +13.73%, with a 14-day RSI of 48.4. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for TECH? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can TECH be incorporated into systematic factor models? ↓
TECH can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.